BCI
BLFS icon

Brinker Capital Investments’s BioLife Solutions BLFS Stock Holding History

Brinker Capital Investments’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,380
Closed -$312K – 1381
2021
Q4 		$312K Buy
+8,380
New +$360K ﹤0.01% 1236

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Brinker Capital Investments's BLFS Position: Q1 2022 in Review

Brinker Capital Investments sold out of BioLife Solutions (BLFS) in Q1 2022, closing a stake of 8,380 shares — an estimated $312K sold.

Brinker Capital Investments first reported a position in BLFS in Q4 2021 and held it in 1 quarter. The position peaked at $312K in Q4 2021. 164 funds tracked by Wall St. Rank hold BLFS as of Q1 2022.

  • Brinker Capital Investments reported no remaining BioLife Solutions position as of Q1 2022 after selling out during the quarter.
  • Brinker Capital Investments sold 8,380 BioLife Solutions shares in Q1 2022, an estimated $312K.
  • Brinker Capital Investments first reported a position in BioLife Solutions in Q4 2021 and held it in 1 quarter.
  • Brinker Capital Investments's BioLife Solutions position peaked at $312K in Q4 2021.
  • 164 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2022.

Based on Brinker Capital Investments's 13F filing for Q1 2022, filed 16 May 2022.